Literature DB >> 7633942

Increased induction of apoptosis in mononuclear cells of a glucose-6-phosphate dehydrogenase deficient patient.

T Efferth1, U Fabry, P Glatte, R Osieka.   

Abstract

Glucose-6-phosphate dehydrogenase (G6PD) deficiency belongs to the most common human disorders of metabolism. In affected patients generation of free radicals causes life-threatening hemolytic crises, for example, after consumption of certain drugs and foods or after infections. Rather than erythrocytes we analyzed mononuclear white blood cells of a patient suffering from G6PD deficiency with respect to their ability to enter apoptosis after treatment with daunorubicin, ionizing radiation, or dexamethasone. The induction of apoptosis was increased in G6PD-deficient cells compared to cells from eight normal donors. In parallel, the glutathione content of mononuclear cells from the G6PD-deficient patient was significantly decreased. While in affected patients decreased life span of erythrocytes damaged by oxidative stress has long been recognized as the mechanism underlying hemolysis, peripheral leukocytes have not received similar attention. Induction of apoptosis is a relatively complex process that has been linked to cellular glutathione content. This is the first report investigating G6PD deficiency and apoptosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7633942     DOI: 10.1007/bf00203619

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  13 in total

1.  Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus.

Authors:  F J Staal; M Roederer; L A Herzenberg; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

2.  GD (--) Aachen, a new variant of deficient glucose-6-phosphate dehydrogenase. Clinical, genetic, biochemical aspects.

Authors:  A Kahn; A Esters; M Habedank
Journal:  Hum Genet       Date:  1976-05-19       Impact factor: 4.132

Review 3.  Pathophysiology of hemolysis in glucose-6-phosphate dehydrogenase deficiency.

Authors:  P Arese; A De Flora
Journal:  Semin Hematol       Date:  1990-01       Impact factor: 3.851

4.  Apoptosis. The role of the endonuclease.

Authors:  M J Arends; R G Morris; A H Wyllie
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

5.  Haemolytic crisis after acetaminophen in glucose-(6)-phosphate dehydrogenase deficiency.

Authors:  B Heintz; T A Bock; H Kierdorf; N Maurin
Journal:  Klin Wochenschr       Date:  1989-10-17

Review 6.  Control of programmed cell death in normal and leukemic cells: new implications for therapy.

Authors:  L Sachs; J Lotem
Journal:  Blood       Date:  1993-07-01       Impact factor: 22.113

Review 7.  Toward an understanding of the molecular mechanisms of physiological cell death.

Authors:  D L Vaux
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

8.  The role of reduced glutathione during the course of acute haemolysis in glucose-6-phosphate dehydrogenase deficient patients: clinical and pharmacodynamic aspects.

Authors:  G G Corbucci
Journal:  Int J Clin Pharmacol Res       Date:  1990

9.  [Broad beans as a cause of acute hemolytic anemia].

Authors:  R L Riepl; J Schreiner; B Müller; S Hildemann; K Loeschke
Journal:  Dtsch Med Wochenschr       Date:  1993-06-25       Impact factor: 0.628

10.  Diverse point mutations in the human glucose-6-phosphate dehydrogenase gene cause enzyme deficiency and mild or severe hemolytic anemia.

Authors:  T J Vulliamy; M D'Urso; G Battistuzzi; M Estrada; N S Foulkes; G Martini; V Calabro; V Poggi; R Giordano; M Town
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

View more
  6 in total

1.  No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapy.

Authors:  Katherine M Robinson; Wenjian Yang; Seth E Karol; Nancy Kornegay; Dennis Jay; Cheng Cheng; John K Choi; Dario Campana; Ching-Hon Pui; Brent Wood; Michael J Borowitz; Julie Gastier-Foster; Eric C Larsen; Naomi Winick; William L Carroll; Mignon L Loh; Elizabeth A Raetz; Stephen P Hunger; Meenakshi Devidas; Elaine R Mardis; Robert S Fulton; Mary V Relling; Sima Jeha
Journal:  Pediatr Blood Cancer       Date:  2019-03-07       Impact factor: 3.167

2.  Somatic-cell selection is a major determinant of the blood-cell phenotype in heterozygotes for glucose-6-phosphate dehydrogenase mutations causing severe enzyme deficiency.

Authors:  S Filosa; N Giacometti; C Wangwei; D De Mattia; D Pagnini; F Alfinito; F Schettini; L Luzzatto; G Martini
Journal:  Am J Hum Genet       Date:  1996-10       Impact factor: 11.025

Review 3.  Apoptosis: clinical relevance and pharmacological manipulation.

Authors:  U Thatte; S Dahanukar
Journal:  Drugs       Date:  1997-10       Impact factor: 9.546

Review 4.  Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease.

Authors:  Peter A Hecker; Jane A Leopold; Sachin A Gupte; Fabio A Recchia; William C Stanley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-15       Impact factor: 4.733

5.  Endotoxemia down-regulates bone marrow lymphopoiesis but stimulates myelopoiesis: the effect of G6PD deficiency.

Authors:  Rachna Chandra; Erika Villanueva; Eleonora Feketova; George W Machiedo; György Haskó; Edwin A Deitch; Zoltán Spolarics
Journal:  J Leukoc Biol       Date:  2008-03-19       Impact factor: 4.962

6.  Glucose-6-phosphate dehydrogenase (G6PD)-deficient epithelial cells are less tolerant to infection by Staphylococcus aureus.

Authors:  Yi-Ting Hsieh; Mei-Hui Lin; Hung-Yao Ho; Lei-Chin Chen; Chien-Cheng Chen; Jwu-Ching Shu
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.